Oxford University Innovation Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Oxford University Innovation Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9304
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oxford University Innovation Ltd (Oxford University Innovation), formerly Isis Innovation Ltd a subsidiary of University of Oxford is a technology transfer university that offers academic consulting services and leads to research and education. The university offers university consulting, medical diagnostics, energy efficiency, electronic displays, medical imaging, consumer product, scientific software, satellite equipment, innovation consultancy, health outcome management and incubator services. Its include incubator services include advice and monitoring; brand and marketing; cloud, company documentation, facilities and funding support among others. Oxford University Innovation consultancy services comprise technology transfer and commercialization training, technology transfer services, technology commercialization and innovation management services. The university handles projects in the areas of life sciences, physical sciences, social sciences and humanities. Oxford University Innovation is headquartered in Oxford, the UK.

Oxford University Innovation Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford University Innovation Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Orbit Discovery Secures USD9.27 Million in Series A Funding Round 11
Partnerships 13
Evotec Partners with University of Oxford, Oxford University Innovation and Oxford Sciences Innovation 13
Licensing Agreements 14
Nightstar Therapeutics Enters into Licensing Agreement with Oxford University Innovation 14
NightstaRx Enters into Licensing Agreement with Oxford University 15
Rogne Bioscience Enters Into Licensing Agreement with Isis Innovation 16
NightstaRx Expands Licensing Agreement with Isis Innovation 17
NightstaRx Enters into Licensing Agreement with Oxford University Innovation 18
Oxford University Innovation Ltd – Key Competitors 19
Oxford University Innovation Ltd – Key Employees 20
Oxford University Innovation Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford University Innovation Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford University Innovation Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Orbit Discovery Secures USD9.27 Million in Series A Funding Round 11
Evotec Partners with University of Oxford, Oxford University Innovation and Oxford Sciences Innovation 13
Nightstar Therapeutics Enters into Licensing Agreement with Oxford University Innovation 14
NightstaRx Enters into Licensing Agreement with Oxford University 15
Rogne Bioscience Enters Into Licensing Agreement with Isis Innovation 16
NightstaRx Expands Licensing Agreement with Isis Innovation 17
NightstaRx Enters into Licensing Agreement with Oxford University Innovation 18
Oxford University Innovation Ltd, Key Competitors 19
Oxford University Innovation Ltd, Key Employees 20
Oxford University Innovation Ltd, Other Locations 21

List of Figures
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Oxford University Innovation Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Oxford University Innovation Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Oxford University Innovation Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rompetrol Rafinare SA (RRC):企業の財務・戦略的SWOT分析
    Rompetrol Rafinare SA (RRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Atmos Energy Corp (ATO):企業の財務・戦略的SWOT分析
    Atmos Energy Corp (ATO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Jagatjit Industries Limited:企業の戦略・SWOT・財務情報
    Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report Summary Jagatjit Industries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • ValiRx Plc (VAL):企業の財務・戦略的SWOT分析
    Summary ValiRx Plc (ValiRx) is a life science company that develops therapeutics for the treatment of clinical stage cancer. The company’s products include VAL201-prostate cancer, VAL401-lung cancer, GeneICE – BCL-2, and NAV3 cancer screening test. It uses GeneICE technology, which enables silencing …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • TSO3 Inc (TOS):医療機器:M&Aディール及び事業提携情報
    Summary TSO3 Inc (TSO3) designs develops, manufactures, markets and licenses sterilization processes for heat-sensitive medical devices. The company’s area of focus is sterile processing, which provides a replacement solution to other low temperature sterilization processes used in hospitals. The co …
  • The Capital Group Companies, Inc.:企業の戦略・SWOT・財務分析
    The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Capital Group Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Chevron Corp (CVX):企業の財務・戦略的SWOT分析
    Chevron Corp (CVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CIRCOR International, Inc. (CIR)-石油・ガス分野:企業M&A・提携分析
    Summary CIRCOR International, Inc. (CIRCOR) is an industrial equipment company that designs, manufactures, and markets flow control solutions and engineered products and sub-systems. Its product offerings include integrated flow control solutions, high pressure pneumatic systems, valves, actuation, …
  • Simon Property Group Inc (SPG):企業の財務・戦略的SWOT分析
    Simon Property Group Inc (SPG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Arkansas Electric Cooperative Corporation:発電所・企業SWOT分析
    Arkansas Electric Cooperative Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • Huntington Memorial Hospital:企業の戦略的SWOT分析
    Huntington Memorial Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Suheung Capsule Co Ltd (008490):企業の財務・戦略的SWOT分析
    Suheung Capsule Co Ltd (008490) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Hallmark Cards, Inc.:企業の戦略・SWOT・財務情報
    Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hallmark Cards, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Genisphere LLC-医療機器分野:企業M&A・提携分析
    Summary Genisphere LLC (Genisphere) is a nanotechnology company which provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapuetics. It develops pipeline produc …
  • The Hongkong and Shanghai Banking Corp Ltd:企業の戦略的SWOT分析
    The Hongkong and Shanghai Banking Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Sinofert Holdings Ltd (297):企業の財務・戦略的SWOT分析
    Sinofert Holdings Ltd (297) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Wharf (Holdings) Limited:企業の戦略・SWOT・財務分析
    The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary The Wharf (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Massachusetts General Hospital:医療機器:M&Aディール及び事業提携情報
    Summary Massachusetts General Hospital (MGH) is a healthcare service provider which offers research, education and therapeutic care services. The hospital provides treatment and patient care services in the therapeutic areas of allergy and immunology; hematology, orthopaedics, neurology and neurosur …
  • Fidia farmaceutici SpA-製薬・医療分野:企業M&A・提携分析
    Summary Fidia farmaceutici SpA (Fidia), a subsidiary of P&R S.p.A., is a healthcare products provider that specializes in research, development and manufacturing of hyaluronic acid-based products. The company develops and commercializes products for specific therapeutic areas which includes joint he …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆